Analystreport

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report